File(s) not publicly available
N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms
journal contribution
posted on 2022-09-29, 06:32 authored by Erica Neill, Susan L Rossell, Caitlin Yolland, Denny Meyer, Cherrie Galletly, Anthony Harris, Dan Siskind, Michael BerkMichael Berk, Kiymet Bozaoglu, Frances Dark, Olivia DeanOlivia Dean, Paul FrancisPaul Francis, Dennis Liu, Andrea Phillipou, Jerome Sarris, David J CastleN-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms
History
Journal
SCHIZOPHRENIA BULLETINPublisher
OXFORD UNIV PRESSPublisher DOI
ISSN
0586-7614eISSN
1745-1701Language
EnglishUsage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC